9-[5-(Hydroxymethyl)tetrahydrofuran-2-yl]-9h-purin-6-ol (BioDeep_00000841988)

   


代谢物信息卡片


9-[5-(Hydroxymethyl)tetrahydrofuran-2-yl]-9h-purin-6-ol

化学式: C10H12N4O3 (236.0909362)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CC(OC1CO)N2C=NC3=C2N=CNC3=O
InChI: InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)

描述信息

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

同义名列表

1 个代谢物同义名

9-[5-(Hydroxymethyl)tetrahydrofuran-2-yl]-9h-purin-6-ol



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Julie Høgh, Malene Hove-Skovsgaard, Marco Gelpi, Anne Marie Reimer Jensen, Jan Gerstoft, Thomas Benfield, Heidi Storgaard, Susanne Dam Nielsen. Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency. BMC infectious diseases. 2022 May; 22(1):503. doi: 10.1186/s12879-022-07485-1. [PMID: 35643429]
  • Marco Gelpi, Andreas Dehlbæk Knudsen, Karoline Brostrup Larsen, Amanda Mocroft, Anne-Mette Lebech, Birgitte Lindegaard, Jens Lundgren, Klaus Fuglsang Kofoed, Susanne Dam Nielsen. Long-lasting alterations in adipose tissue density and adiponectin production in people living with HIV after thymidine analogues exposure. BMC infectious diseases. 2019 Aug; 19(1):708. doi: 10.1186/s12879-019-4347-y. [PMID: 31399063]
  • Nongodo Firmin Kaboré, Armel Poda, Jacques Zoungrana, Ollo Da, Laura Ciaffi, Aoua Semdé, Issouf Yaméogo, Adrien B Sawadogo, Eric Delaporte, Nicolas Meda, Sophie Limou, Amandine Cournil. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting. BMC nephrology. 2019 05; 20(1):155. doi: 10.1186/s12882-019-1335-9. [PMID: 31064340]
  • Hongxiang Chen, Gang Wang, Lanzhen Sun, Huicong Zhang, Mengchi Sun, Jin Sun, Lei Shang, Cong Luo. Regulating the alky chain length of fatty acid-didanosine prodrugs and evaluating its role in albumin binding. Drug delivery and translational research. 2018 02; 8(1):21-31. doi: 10.1007/s13346-017-0428-x. [PMID: 28944416]
  • Aylin B Unsal, Aviva S Mattingly, Sara E Jones, Julia B Purdy, James C Reynolds, Jeffrey B Kopp, Rohan Hazra, Colleen M Hadigan. Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life. The Journal of clinical endocrinology and metabolism. 2017 08; 102(8):2896-2904. doi: 10.1210/jc.2017-00197. [PMID: 28531309]
  • Opass Putcharoen, Lalita Wattanachanya, Jiratchaya Sophonphan, Sarawut Siwamogsatham, Vorapot Sapsirisavat, Sivaporn Gatechompol, Supalak Phonphithak, Stephen J Kerr, Pairoj Chattranukulchai, Yingyos Avihingsanon, Kiat Ruxrungtham, Anchalee Avihingsanon. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS (London, England). 2017 07; 31(11):1535-1543. doi: 10.1097/qad.0000000000001496. [PMID: 28398958]
  • Karanam Anandan Suresh, Venkata Subbaiah C Kadiam, Thaslim S K Basha, Naga Raju Chamarti, Suresh M Kumar, Rajendra Wudayagiri, Lokanatha Valluru. Synthesis and Antiviral Activity of Novel Phosphorylated Derivatives of Didanosine Against Newcastle Disease Virus in Chicken. Archiv der Pharmazie. 2016 Jun; 349(6):442-55. doi: 10.1002/ardp.201600038. [PMID: 27128998]
  • Noris Pavia-Ruz, Magdel Rossouw, Xavier Sáez-Llorens, Torsak Bunupuradah, Mathew Taylor, Rong Yang, Heather Sevinsky, Mark Krystal, Max Lataillade, Daniel Seekins, Sophie Biguenet. Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922. The Pediatric infectious disease journal. 2015 Dec; 34(12):1355-60. doi: 10.1097/inf.0000000000000913. [PMID: 26379163]
  • Xu Lan, Lei Mingdao, Guo Huilin, Gan Wei, Hu Lvjiang, Zhou Yan, Li Gang. Simultaneous determination of 2',3'-dideoxyinosine and the active metabolite, 2',3'-dideoxyadenosine-5'-triphosphate in human peripheral-blood mononuclear cell by HPLC-MS/MS and the application to cell pharmacokinetics. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2015 Oct; 1002(?):337-42. doi: 10.1016/j.jchromb.2015.08.039. [PMID: 26350426]
  • Rupak Shivakoti, Nikhil Gupte, Wei-Teng Yang, Noluthando Mwelase, Cecilia Kanyama, Alice M Tang, Sandy Pillay, Wadzanai Samaneka, Cynthia Riviere, Sima Berendes, Javier R Lama, Sandra W Cardoso, Patcharaphan Sugandhavesa, Richard D Semba, Parul Christian, Thomas B Campbell, Amita Gupta. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy. Nutrients. 2014 Nov; 6(11):5061-78. doi: 10.3390/nu6115061. [PMID: 25401501]
  • Keishiro Yajima, Tomoko Uehira, Hiroshi Otera, Yusuke Koizumi, Dai Watanabe, Yoshinori Kodama, Noriyoshi Kuzushita, Yasuharu Nishida, Eiji Mita, Masayuki Mano, Takuma Shirasaka. A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2014 Sep; 20(9):582-5. doi: 10.1016/j.jiac.2014.06.005. [PMID: 25034388]
  • Elsabé Jones, Elizabeth Ojewole, Rahul Kalhapure, Thirumala Govender. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy. Drug development and industrial pharmacy. 2014 May; 40(5):669-79. doi: 10.3109/03639045.2014.892957. [PMID: 24576267]
  • Hervé Hillaireau, Nathalie Dereuddre-Bosquet, Rym Skanji, Fawzia Bekkara-Aounallah, Joachim Caron, Sinda Lepêtre, Sébastien Argote, Laurent Bauduin, Rahima Yousfi, Christine Rogez-Kreuz, Didier Desmaële, Bernard Rousseau, Ruxandra Gref, Karine Andrieux, Pascal Clayette, Patrick Couvreur. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies. Biomaterials. 2013 Jul; 34(20):4831-8. doi: 10.1016/j.biomaterials.2013.03.022. [PMID: 23562054]
  • H Hien, N Meda, S Diagbouga, E Zoure, S Yaméogo, H Tamboura, J Somé, A Ouiminga, F Rouet, A Drabo, A Hien, J Nicolas, H Chappuy, P Van de Perre, P Msellati, B Nacro. 24-Month adherence, tolerance and efficacy of once-a-day antiretroviral therapy with didanosine, lamivudine, and efavirenz in African HIV-1 infected children: ANRS 12103/12167. African health sciences. 2013 Jun; 13(2):287-94. doi: 10.4314/ahs.v13i2.13. [PMID: 24235926]
  • Eugenia Vispo, Muge Cevik, Juergen K Rockstroh, Pablo Barreiro, Mark Nelson, Andrew Scourfield, Christoph Boesecke, Jan-Christian Wasmuth, Vincent Soriano. Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Apr; 56(8):1117-22. doi: 10.1093/cid/cit001. [PMID: 23315321]
  • Naïm Bouazza, Jean-Marc Tréluyer, Philippe Msellati, Philippe Van de Perre, Serge Diagbouga, Boubacar Nacro, Hervé Hien, Emmanuelle Zoure, François Rouet, Adama Ouiminga, Stephane Blanche, Déborah Hirt, Saik Urien. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. AIDS (London, England). 2013 Mar; 27(5):761-8. doi: 10.1097/qad.0b013e32835caad1. [PMID: 23719348]
  • N N Guimarães, C J Silva, H H R de Andrade, R R Dihl, M Lehmann, K S Cunha. Comparative analysis of genetic toxicity of antiretroviral combinations in somatic cells of Drosophila melanogaster. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2013 Mar; 53(?):299-309. doi: 10.1016/j.fct.2012.12.005. [PMID: 23261680]
  • T C S Martin, A Scourfield, N Rockwood, N K Martin, N Patel, M Nelson, B G Gazzard. Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned. HIV medicine. 2013 Mar; 14(3):161-6. doi: 10.1111/j.1468-1293.2012.01047.x. [PMID: 22994793]
  • T Suárez-Zarracina, E Valle-Garay, J Collazos, A H Montes, V Cárcaba, J A Carton, V Asensi. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients. Journal of viral hepatitis. 2012 Oct; 19(10):685-93. doi: 10.1111/j.1365-2893.2012.01596.x. [PMID: 22967099]
  • Didier Desmaële, Ruxandra Gref, Patrick Couvreur. Squalenoylation: a generic platform for nanoparticular drug delivery. Journal of controlled release : official journal of the Controlled Release Society. 2012 Jul; 161(2):609-18. doi: 10.1016/j.jconrel.2011.07.038. [PMID: 21840355]
  • Kasongo Wa Kasongo, Rainer H Müller, Roderick B Walker. The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients. Pharmaceutical development and technology. 2012 May; 17(3):353-62. doi: 10.3109/10837450.2010.542163. [PMID: 21241166]
  • Alberto Diez-Torrubia, Silvia Cabrera, Anne-Marie Lambeir, Jan Balzarini, María-José Camarasa, Sonsoles Velázquez. Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs. ChemMedChem. 2012 Apr; 7(4):618-28. doi: 10.1002/cmdc.201100504. [PMID: 22307932]
  • Elizabeth Ojewole, Irene Mackraj, Kamil Akhundov, Josias Hamman, Alvaro Viljoen, Eugene Olivier, James Wesley-Smith, Thirumala Govender. Investigating the effect of Aloe vera gel on the buccal permeability of didanosine. Planta medica. 2012 Mar; 78(4):354-61. doi: 10.1055/s-0031-1280431. [PMID: 22161764]
  • Thomas Aschacher, Sandra Sampl, Lisa Käser, David Bernhard, Andreas Spittler, Klaus Holzmann, Michael Bergmann. The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations. Neoplasia (New York, N.Y.). 2012 Jan; 14(1):44-53. doi: 10.1593/neo.11426. [PMID: 22355273]
  • Slim Fourati, Isabelle Malet, Carolin A Guenzel, Cathia Soulie, Priscilla Maidou-Peindara, Laurence Morand-Joubert, Marc Wirden, Sophie Sayon, Gilles Peytavin, Anne Simon, Christine Katlama, Serge Benichou, Vincent Calvez, Anne-Geneviève Marcelin. E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations. Antiviral research. 2012 Jan; 93(1):167-74. doi: 10.1016/j.antiviral.2011.11.008. [PMID: 22138483]
  • Kasongo Wa Kasongo, Jana Pardeike, Rainer H Müller, Roderick B Walker. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Journal of pharmaceutical sciences. 2011 Dec; 100(12):5185-96. doi: 10.1002/jps.22711. [PMID: 22020815]
  • Kasongo Wa Kasongo, Mirko Jansch, Rainer H Müller, Roderick B Walker. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain. Journal of liposome research. 2011 Sep; 21(3):245-54. doi: 10.3109/08982104.2010.539186. [PMID: 21174528]
  • Rym Skanji, Karine Andrieux, Muriel Lalanne, Joachim Caron, Claudie Bourgaux, Jéril Degrouard, François Brisset, Claire Gueutin, Hélène Chacun, Nathalie Dereuddre-Bosquet, Angelo Paci, Gilles Vassal, Laurent Bauduin, Sébastien Garcia-Argote, Bernard Rousseau, Pascal Clayette, Didier Desmaële, Patrick Couvreur. A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary. International journal of pharmaceutics. 2011 Jul; 414(1-2):285-97. doi: 10.1016/j.ijpharm.2011.05.005. [PMID: 21596125]
  • Makoura Barro, Jérôme Some, Vincent Foulongne, Yaya Diasso, Emmanuelle Zouré, Hervé Hien, Rouet François, Segondy Michel, Aly Drabo, Hassane Tamboura, Adama Ouiminga, Serge Diagbouga, Alain Hien, Souleymane Yaméogo, Philippe Van De Perre, Boubacar Nacro, Philippe Msellati. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. Journal of acquired immune deficiency syndromes (1999). 2011 Jul; 57 Suppl 1(?):S44-9. doi: 10.1097/qai.0b013e31821fd64f. [PMID: 21857286]
  • Luis Mérida, Javier de la Torre, Julián Olalla, Mariam Noureddine, Alfonso del Arco, José Luis Prada, Ana Aguilar, Javier García-Alegría. [Protective role of antiretroviral treatment in the impairment of renal function in a cohort of human immunodeficiency virus patients]. Medicina clinica. 2011 Jun; 137(3):104-7. doi: 10.1016/j.medcli.2010.09.049. [PMID: 21397277]
  • Yiguang Jin, Rui Xin, Li Tong, Lina Du, Miao Li. Combination anti-HIV therapy with the self-assemblies of an asymmetric bolaamphiphilic zidovudine/didanosine prodrug. Molecular pharmaceutics. 2011 Jun; 8(3):867-76. doi: 10.1021/mp100457d. [PMID: 21553876]
  • Zhongtian Yan, Jin Sun, Yannan Chang, Yanhua Liu, Qiang Fu, Youjun Xu, Yongbing Sun, Xiaohui Pu, Youxi Zhang, Yongkui Jing, Shiliang Yin, Meng Zhu, Yongjun Wang, Zhonggui He. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics. Molecular pharmaceutics. 2011 Apr; 8(2):319-29. doi: 10.1021/mp100376q. [PMID: 21280612]
  • Kasongo Wa Kasongo, Ranjita Shegokar, Rainer H Müller, Roderick B Walker. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex. Drug development and industrial pharmacy. 2011 Apr; 37(4):396-407. doi: 10.3109/03639045.2010.516264. [PMID: 20923388]
  • Heidi M Crane, Carl Grunfeld, James H Willig, Michael J Mugavero, Stephen Van Rompaey, Richard Moore, Benigno Rodriguez, Betsy J Feldman, Michael M Lederman, Michael S Saag, Mari M Kitahata. Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care. AIDS (London, England). 2011 Jan; 25(2):185-95. doi: 10.1097/qad.0b013e328341f925. [PMID: 21150555]
  • Sébastien Gallien, Valérie Journot, Willy Rozenbaum, Patrick Yéni, Philippe Morlat, Isabelle Poizot-Martin, Jacques Reynes, Véronique Reliquet, Pascale Leclercq, François Simon, Geneviève Chêne, Jean-Michel Molina. Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial). The Journal of antimicrobial chemotherapy. 2011 Jan; 66(1):184-91. doi: 10.1093/jac/dkq395. [PMID: 21036772]
  • Juan Manuel Tiraboschi, Jordi Niubo, Jordi Curto, Daniel Podzamczer. Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999). 2010 Dec; 55(5):606-9. doi: 10.1097/qai.0b013e3181ef70fe. [PMID: 20706127]
  • D De Forni, M R Stevens, F Lori. Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in [corrected] HIV/AIDS. British journal of pharmacology. 2010 Oct; 161(4):830-43. doi: 10.1111/j.1476-5381.2010.00940.x. [PMID: 20860662]
  • Naïm Bouazza, Déborah Hirt, Christophe Bardin, Serge Diagbouga, Boubacar Nacro, Hervé Hien, Emmanuelle Zoure, François Rouet, Adama Ouiminga, Stephane Blanche, Philippe Van De Perre, Jean-Marc Tréluyer, Philippe Msellati, Saik Urien. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?. Antimicrobial agents and chemotherapy. 2010 Aug; 54(8):3280-6. doi: 10.1128/aac.00306-10. [PMID: 20516271]
  • Abeer M Al-Ghananeem, Hayder Saeed, Rebecca Florence, Robert A Yokel, Ahmad H Malkawi. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses. Journal of drug targeting. 2010 Jun; 18(5):381-8. doi: 10.3109/10611860903483396. [PMID: 20001275]
  • Roland Landman, M B Diallo, N F Ngom Gueye, C Toure Kane, S Mboup, M B Koita Fall, B Ndiaye, G Peytavin, Y Bennai, A Benalycherif, P M Girard, P S Sow. Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal. AIDS research and human retroviruses. 2010 May; 26(5):519-25. doi: 10.1089/aid.2009.0123. [PMID: 20455760]
  • Marc Lallemant, Nicole Ngo-Giang-Huong, Gonzague Jourdain, Patrinee Traisaithit, Tim R Cressey, Intira J Collins, Tapnarong Jarupanich, Thammanoon Sukhumanant, Jullapong Achalapong, Prapan Sabsanong, Nantasak Chotivanich, Narong Winiyakul, Surabon Ariyadej, Annop Kanjanasing, Janyaporn Ratanakosol, Jittapol Hemvuttiphan, Karun Kengsakul, Wiroj Wannapira, Veerachai Sittipiyasakul, Witaya Pornkitprasarn, Prateung Liampongsabuddhi, Kenneth McIntosh, Russell B Van Dyke, Lisa M Frenkel, Suporn Koetsawang, Sophie Le Coeur, Siripon Kanchana. Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Mar; 50(6):898-908. doi: 10.1086/650745. [PMID: 20158398]
  • Zhongtian Yan, Jin Sun, Jinling Wang, Youjun Xu, Yannan Chang, Ping Meng, Meng Zhu, Qiang Fu, Yongbing Sun, Zhonggui He. Simultaneous determination of didanosine and its amino acid prodrug, valdidanosine by hydrophilic interaction chromatography coupled with electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study in rats. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2010 Feb; 878(3-4):466-70. doi: 10.1016/j.jchromb.2009.11.041. [PMID: 20022566]
  • Diane Descamps, Corine Chazallon, Clive Loveday, Lee Bacheler, Ruth Goodall, Patrick Yéni, David A Cooper, Abdel Babiker, Jean-Pierre Aboulker, Francoise Brun-Vézinet. Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trial. HIV clinical trials. 2009 Nov; 10(6):385-93. doi: 10.1310/hct1006-385. [PMID: 20133269]
  • Manuel Mendizabal, Soledad Craviotto, Terina Chen, Marcelo O Silva, K Rajender Reddy. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients. Annals of hepatology. 2009 Oct; 8(4):390-5. doi: 10.1016/s1665-2681(19)31757-0. [PMID: 20009143]
  • Déborah Hirt, Christophe Bardin, Serge Diagbouga, Boubacar Nacro, Hervé Hien, Emmanuelle Zoure, François Rouet, Adama Ouiminga, Saik Urien, Vincent Foulongne, Philippe Van De Perre, Jean-Marc Tréluyer, Philippe Msellati. Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment. Antimicrobial agents and chemotherapy. 2009 Oct; 53(10):4399-406. doi: 10.1128/aac.01187-08. [PMID: 19581461]
  • Sverre Høyem, Skjalg Bruheim, Gunhild Maelandsmo, Marius Standal, Dag Erlend Olberg, Bjarne Brudeli, Anders Asberg, Jo Klaveness, Pål Rongved. Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats. European journal of medicinal chemistry. 2009 Oct; 44(10):3874-9. doi: 10.1016/j.ejmech.2009.04.008. [PMID: 19433342]
  • Mia Yu, Yvona Ward, Miriam C Poirier, Ofelia A Olivero. Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine. Environmental and molecular mutagenesis. 2009 Oct; 50(8):718-24. doi: 10.1002/em.20509. [PMID: 19562754]
  • Yu Zhu, David Vergote, Carlos Pardo, Farshid Noorbakhsh, Justin C McArthur, Morley D Hollenberg, Christopher M Overall, Christopher Power. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2009 Sep; 23(9):2928-41. doi: 10.1096/fj.08-128819. [PMID: 19380511]
  • Huaying Zhou, Yuhuang Zheng, Yan He, Guozhong Gong, Zi Chen, Meng Liu, Wei Yin, Chun Liu. [Therapeutic effect and safety evaluation on 6-year highly active antiretroviral therapy for Chinese HIV-1 infected patients]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2009 Aug; 34(8):731-7. doi: . [PMID: 19734579]
  • Dirk Lebrecht, Ana C Venhoff, Janbernd Kirschner, Thorsten Wiech, Nils Venhoff, Ulrich A Walker. Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats. Journal of acquired immune deficiency syndromes (1999). 2009 Jul; 51(3):258-63. doi: 10.1097/qai.0b013e3181a666eb. [PMID: 19582894]
  • James J Kohler, Seyed H Hosseini, Amy Hoying-Brandt, Elgin Green, David M Johnson, Rodney Russ, Dung Tran, C Michael Raper, Robert Santoianni, William Lewis. Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Laboratory investigation; a journal of technical methods and pathology. 2009 May; 89(5):513-9. doi: 10.1038/labinvest.2009.14. [PMID: 19274046]
  • Hermann Bussmann, C William Wester, Ann Thomas, Vladimir Novitsky, Reginald Okezie, Tanaka Muzenda, Tendani Gaolathe, Ndwapi Ndwapi, Norah Mawoko, Erik Widenfelt, Sikhulile Moyo, Rosemary Musonda, Madisa Mine, Joseph Makhema, Howard Moffat, Max Essex, Victor Degruttola, Richard G Marlink. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. Journal of acquired immune deficiency syndromes (1999). 2009 May; 51(1):37-46. doi: 10.1097/qai.0b013e31819ff102. [PMID: 19282782]
  • Katsuhiro Suzuki, Masatoki Katayama, Kiyoshi Takamatsu, Satoru Kaneko, Keisuke Miyaji, Hiromichi Ishikawa, Yoshifumi Matsuda. Improvement of sensitivity and selectivity of high-performance liquid chromatography for anti-retroviral drugs (non-reverse transcriptase inhibitors) by diamond-electrode electrochemical and fluorescence detection. Journal of chromatography. A. 2009 Apr; 1216(15):3117-21. doi: 10.1016/j.chroma.2009.01.109. [PMID: 19233377]
  • Mohamed G Atta, Derek M Fine. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice. The AIDS reader. 2009 Mar; 19(3):118-9. doi: NULL. [PMID: 19334329]
  • Yiguang Jin, Ping Ai, Rui Xin, Ying Tian, Junxing Dong, Dawei Chen, Wei Wang. Self-assembled drug delivery systems: Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine. International journal of pharmaceutics. 2009 Feb; 368(1-2):207-14. doi: 10.1016/j.ijpharm.2008.10.009. [PMID: 19007871]
  • Sonia Hernández-Díaz, Allen A Mitchell, Katherine E Kelley, Antonia M Calafat, Russ Hauser. Medications as a potential source of exposure to phthalates in the U.S. population. Environmental health perspectives. 2009 Feb; 117(2):185-9. doi: 10.1289/ehp.11766. [PMID: 19270786]
  • Yiguang Jin, Ping Ai, Rui Xin, Dawei Chen. Morphological transformation of self-assembled nanostructures prepared from cholesteryl acyl didanosine and the optimal formulation of nanoparticulate systems: effects of solvents, acyl chain length and poloxamer 188. Journal of colloid and interface science. 2008 Oct; 326(1):275-82. doi: 10.1016/j.jcis.2008.07.014. [PMID: 18672249]
  • . Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS (London, England). 2008 Sep; 22(14):F17-24. doi: 10.1097/qad.0b013e32830fe35e. [PMID: 18753925]
  • B Hernández-Novoa, A Antela, C Gutiérrez, J A Pérez-Molina, M J Pérez-Elías, F Dronda, A Moreno, J L Casado, C Page, M Pumares, J C Galán, S Moreno. Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study. HIV medicine. 2008 Apr; 9(4):187-91. doi: 10.1111/j.1468-1293.2008.00543.x. [PMID: 18298579]
  • Sanjay K Jain, Yashwant Gupta, Anekant Jain, Asheesh R Saxena, Piush Khare, Aviral Jain. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine : nanotechnology, biology, and medicine. 2008 Mar; 4(1):41-8. doi: 10.1016/j.nano.2007.11.004. [PMID: 18207463]
  • Stefania Notari, Carmine Mancone, Tonino Alonzi, Marco Tripodi, Pasquale Narciso, Paolo Ascenzi. Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration in human plasma by MALDI-TOF/TOF. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2008 Mar; 863(2):249-57. doi: 10.1016/j.jchromb.2008.01.009. [PMID: 18258495]
  • Matthias Mehling, Henning Drechsler, Jens Kuhle, Martin Hardmeier, Ruediger Doerries, Stephan Ruegg, Achim Gass. Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement. Journal of neurovirology. 2008 Jan; 14(1):78-84. doi: 10.1080/13550280701793940. [PMID: 18300078]
  • Jesús Santos, Rosario Palacios, Fernando Lozano, Manuel López, María Carmen Gálvez, Javier de la Torres, Luis Fernando López-Cortés, María José Ríos, Antonio Rivero. Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up. AIDS research and human retroviruses. 2008 Jan; 24(1):24-6. doi: 10.1089/aid.2007.0142. [PMID: 18275344]
  • Carlos Illana Esteban. [Cordyceps sinensis, a fungi used in the Chinese traditional medicine]. Revista iberoamericana de micologia. 2007 Dec; 24(4):259-62. doi: 10.1016/s1130-1406(07)70052-9. [PMID: 18095756]
  • V Svedhem, T Bergroth, K Lidman, A Sönnerborg. Presence of M184I/V in minor HIV-1 populations of patients with lamivudine and/or didanosine treatment failure. HIV medicine. 2007 Nov; 8(8):504-10. doi: 10.1111/j.1468-1293.2007.00502.x. [PMID: 17944683]
  • Anna Canestri, Papa Salif Sow, Muriel Vray, Fatou Ngom, Souleymane M'boup, Coumba Toure Kane, Eric Delaporte, Mandoumé Gueye, Gilles Peytavin, Pierre Marie Girard, Roland Landman. Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal. MedGenMed : Medscape general medicine. 2007 Oct; 9(4):7. doi: . [PMID: 18311357]
  • Evguenia S Svarovskaia, Nicolas A Margot, Andrew S Bae, Joshua M Waters, Derrick Goodman, Lijie Zhong, Katyna Borroto-Esoda, Michael D Miller. Low-level K65R mutation in HIV-1 reverse transcriptase of treatment-experienced patients exposed to abacavir or didanosine. Journal of acquired immune deficiency syndromes (1999). 2007 Oct; 46(2):174-80. doi: 10.1097/qai.0b013e31814258c0. [PMID: 17667333]
  • Matilde Sánchez-Conde, Rosario Palacios, José Sanz, Sonia Rodríguez-Novoa, Pablo Rivas, Jesús Santos, Julio Sola, Victor Asensi, Carmen de Mendoza, Vicente Estrada, Pablo Barreiro, Juan González-Lahoz, Inmaculada Jiménez-Nacher, Vincent Soriano. Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study. AIDS research and human retroviruses. 2007 Oct; 23(10):1237-41. doi: 10.1089/aid.2006.0029. [PMID: 17961110]
  • Selwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, Fulco van der Veen, Peter Reiss, Joep M A Lange, David M Burger, Sjoerd Repping, Jan M Prins. Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen. Therapeutic drug monitoring. 2007 Oct; 29(5):566-70. doi: 10.1097/ftd.0b013e31811fef29. [PMID: 17898645]
  • James H Willig, Andrew O Westfall, Jeroan Allison, Nicholas Van Wagoner, Pei-Wen Chang, James Raper, Michael S Saag, Michael J Mugavero. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Sep; 45(5):658-61. doi: 10.1086/520653. [PMID: 17683005]
  • Katyna Borroto-Esoda, Joshua M Waters, Andrew S Bae, Jeanette L Harris, John E Hinkle, Joseph B Quinn, Frank S Rousseau. Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz. AIDS research and human retroviruses. 2007 Aug; 23(8):988-95. doi: 10.1089/aid.2006.0310. [PMID: 17725415]
  • Ross E McKinney, John Rodman, Chengcheng Hu, Paula Britto, Michael Hughes, Mary Elizabeth Smith, Leslie K Serchuck, Joyce Kraimer, Alberto A Ortiz, Patricia Flynn, Ram Yogev, Stephen Spector, Linda Draper, Paul Tran, Melissa Scites, Ruth Dickover, Adriana Weinberg, Coleen Cunningham, Elaine Abrams, M Robert Blum, Gregory E Chittick, Laurie Reynolds, Mobeen Rathore. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics. 2007 Aug; 120(2):e416-23. doi: 10.1542/peds.2006-0925. [PMID: 17646352]
  • Heidi M Crane, Bryan Kestenbaum, Robert D Harrington, Mari M Kitahata. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir. AIDS (London, England). 2007 Jul; 21(11):1431-9. doi: 10.1097/qad.0b013e3281fc9320. [PMID: 17589189]
  • Carlo Torti, Giuseppe Lapadula, Pablo Barreiro, Vicente Soriano, Sundhiya Mandalia, Annalisa De Silvestri, Fredy Suter, Franco Maggiolo, Andrea Antinori, Francesco Antonucci, Renato Maserati, Issa El Hamad, Piera Pierotti, Laura Sighinolfi, Guglielmo Migliorino, Nicoletta Ladisa, Giampiero Carosi. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. The Journal of antimicrobial chemotherapy. 2007 Jun; 59(6):1141-7. doi: 10.1093/jac/dkm100. [PMID: 17434879]
  • Kathryn Anastos, Dalian Lu, Qiuhu Shi, Phyllis C Tien, Robert C Kaplan, Nancy A Hessol, Steven Cole, Cheryl Vigen, Mardge Cohen, Mary Young, Jessica Justman. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. Journal of acquired immune deficiency syndromes (1999). 2007 May; 45(1):34-42. doi: 10.1097/qai.0b013e318042d5fe. [PMID: 17460470]
  • Henriëtte J Scherpbier, Vincent Bekker, Dasja Pajkrt, Suzanne Jurriaans, Joep M A Lange, Taco W Kuijpers. Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen. Pediatrics. 2007 Mar; 119(3):e705-15. doi: 10.1542/peds.2006-1367. [PMID: 17308244]
  • G J Claas, B Jülg, F D Goebel, Johannes R Bogner. Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients. European journal of medical research. 2007 Feb; 12(2):54-60. doi: . [PMID: 17369118]
  • Dhrmarajan Sriram, Perumal Yogeeswari, Nagell Raveendra Babu, Purna Nagashree Kurre. Synthesis and in vitro anti-HIV activities of didanosine prodrugs. Journal of enzyme inhibition and medicinal chemistry. 2007 Feb; 22(1):51-5. doi: 10.1080/14756360600988831. [PMID: 17373547]
  • Philippe Flandre, Colombe Chappey, Anne Genevieve Marcelin, Kirk Ryan, Jen-Fue Maa, Mike Bates, Daniel Seekins, Marie Charlotte Bernard, Vincent Calvez, Jean Michel Molina. Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection. The Journal of infectious diseases. 2007 Feb; 195(3):392-8. doi: 10.1086/510754. [PMID: 17205478]
  • Jean-Michel Molina, Valérie Journot, André Furco, Pierre Palmer, Nathalie De Castro, François Raffi, Philippe Morlat, Thierry May, Corinne Rancinan, Geneviève Chêne. Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial). Antiviral therapy. 2007; 12(3):417-22. doi: NULL. [PMID: 17591032]
  • Hua-Ying Zhou, Yu-Huang Zheng, Chun-Ying Zhang, Jun Chen, Yan He, Pei-Pei Ding, Hui Li. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years. Viral immunology. 2007; 20(1):180-7. doi: 10.1089/vim.2006.0047. [PMID: 17425432]
  • David Asboe, Ian G Williams, Ruth L Goodall, Janet H Darbyshire, Malcolm H Hooker, Abdel G Babiker. A virological benefit from an induction/maintenance strategy: the Forte trial. Antiviral therapy. 2007; 12(1):47-54. doi: NULL. [PMID: 17503747]
  • Gerald Friedland, Saye Khoo, Christopher Jack, Umesh Lalloo. Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV. The Journal of antimicrobial chemotherapy. 2006 Dec; 58(6):1299-302. doi: 10.1093/jac/dkl399. [PMID: 17032686]
  • Francesc Vidal, Joan Carles Domingo, Jordi Guallar, Maria Saumoy, Begoña Cordobilla, Rainel Sánchez de la Rosa, Marta Giralt, Maria Luisa Alvarez, Miguel López-Dupla, Ferran Torres, Francesc Villarroya, Tomas Cihlar, Pere Domingo. In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells. Antimicrobial agents and chemotherapy. 2006 Nov; 50(11):3824-32. doi: 10.1128/aac.00437-06. [PMID: 16940060]
  • V Reliquet, C Allavena, C François-Brunet, P Perré, V Bellein, M Garré, T May, F Souala, J-M Besnier, F Raffi. Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study. HIV medicine. 2006 Oct; 7(7):431-6. doi: 10.1111/j.1468-1293.2006.00402.x. [PMID: 16925728]
  • Jose Luis Blanco, Alejandra Biglia, Elisa De Lazzari, Josep Mallolas, Esteban Martinez, Tomás Pumarola, María Larrousse, Ana Milinkovic, Agathe León, Montserrat Lonca, Montserrat Laguno, Josep María Gatell. Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations. AIDS (London, England). 2006 Sep; 20(14):1891-2. doi: 10.1097/01.aids.0000244210.33876.26. [PMID: 16954732]
  • Chulapan Engchanil, Pope Kosalaraksa, Pagakrong Lumbiganon, Viraphong Lulitanond, Piyaporn Pongjunyakul, Ruengsin Thuennadee, Sasithorn Tungsawad, Olan Suwan-apichon. Therapeutic potential of chloroquine added to zidovudine plus didanosine for HIV-1 infected children. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2006 Aug; 89(8):1229-36. doi: . [PMID: 17048434]
  • Christopher M Cirino, Virginia L Kan. Hypokalemia in HIV patients on tenofovir. AIDS (London, England). 2006 Aug; 20(12):1671-3. doi: 10.1097/01.aids.0000238416.05819.09. [PMID: 16868451]
  • José Miguel Benito, Mariola López, Celia Ballesteros, Sara Lozano, Laura Capa, Pablo Barreiro, José Sempere, Juan Gonzalez-Lahoz, Vincent Soriano. Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine. AIDS research and human retroviruses. 2006 Aug; 22(8):734-43. doi: 10.1089/aid.2006.22.734. [PMID: 16910828]
  • Sabiha Hussain, Abeer Khayat, Asad Tolaymat, Mobeen H Rathore. Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir. Pediatric nephrology (Berlin, Germany). 2006 Jul; 21(7):1034-6. doi: 10.1007/s00467-006-0109-3. [PMID: 16773419]
  • T Nicole Clark, Catherine A White, Michael G Bartlett. Determination of didanosine in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography-tandem mass spectrometry. Biomedical chromatography : BMC. 2006 Jun; 20(6-7):605-11. doi: 10.1002/bmc.651. [PMID: 16779780]
  • Eric Balestre, Michel Dupon, Sophie Capdepont, Rodolphe Thiébaut, Sébastien Boucher, Hervé Fleury, François Dabis, Bernard Masquelier. Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2006 Jun; 36(2):95-9. doi: 10.1016/j.jcv.2006.02.002. [PMID: 16556509]
  • M Cruciani, G Liuzzi, A Chirianni, S Audagnotto, S Bonora, A Di Biagio, A Sinicco, M Bassetti, G Gatti. Penetration of didanosine in semen of HIV-1-infected men. The Journal of antimicrobial chemotherapy. 2006 Jun; 57(6):1244-7. doi: 10.1093/jac/dkl111. [PMID: 16556633]
  • Sophie Capdepont, Valérie Aurillac-Lavignolle, Muriel Faure, Michel Dupon, Philippe Morlat, Jean-Marie Ragnaud, Geneviève Chêne, Hervé Fleury, Bernard Masquelier. An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2006 May; 36(1):36-42. doi: 10.1016/j.jcv.2006.01.008. [PMID: 16513416]
  • Teresa García-Benayas, Ana Lucía Rendón, Sonia Rodríguez-Novóa, Ana Barrios, Ivana Maida, Francisco Blanco, Pablo Barreiro, Pablo Rivas, Juan González-Lahoz, Vincent Soriano. Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir. AIDS research and human retroviruses. 2006 Apr; 22(4):333-7. doi: 10.1089/aid.2006.22.333. [PMID: 16623636]
  • Margaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, Jeffrey Coco, Edwin DeJesus, Adriano Lazzarin, Kenneth Lichtenstein, Victoria Wirtz, Anna Rightmire, Linda Odeshoo, Colin McLaren. 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures. AIDS (London, England). 2006 Mar; 20(5):711-8. doi: 10.1097/01.aids.0000216371.76689.63. [PMID: 16514301]
  • Robert W Robey, Zhirong Zhan, Richard L Piekarz, Ganesh L Kayastha, Tito Fojo, Susan E Bates. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Mar; 12(5):1547-55. doi: 10.1158/1078-0432.ccr-05-1423. [PMID: 16533780]
  • Simone Schramm Andrade, Eunice Kazue Kano, Tatiane Maria de Lima Souza Brioschi, Eunice Emiko Mori Koono, Cristina Helena dos Reis Serra, Valentina Porta. Bioavailability study of two oral formulations of didanosine in healthy volunteers. Arzneimittel-Forschung. 2006; 56(5):359-64. doi: 10.1055/s-0031-1296734. [PMID: 16821647]
  • Hélène C F Côté, Alex B Magil, Marianne Harris, Brian J Scarth, Izabelle Gadawski, Nancy Wang, Eugenia Yu, Benita Yip, Nadia Zalunardo, Ron Werb, Robert Hogg, P Richard Harrigan, Julio S Montaner. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antiviral therapy. 2006; 11(1):79-86. doi: NULL. [PMID: 16518963]